Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Major pharmaceutical firms in China have invested heavily in GLP-1-related research and development as a means of capitalizing on growing demand for weight management and diabetes treatment
2018 , , , ,
SUSTAIN Clinical Trial Series : The Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) trials encompass a series of clinical studies evaluating the efficacy and safety of semaglutide in managing type 2 diabetes
In the published literature, afamelanotide is studied as an agonist at melanocortin receptors, principally the melanocortin-1 receptor (MC1R), within in-vitro systems and pre-clinical models
US$ 29.24
US$ 27.59
US$ 23.22
US$ 25.58
US$ 27.86
US$ 20.56
US$ 28.00
